CT 脂肪肌肉分数预测二尖瓣钳夹术后结局
本研究纳入 197 例接受经导管二尖瓣缘对缘修复术且术前有增强 CT 的患者,利用深度学习分割 L3 层面骨骼肌并测量脂肪肌肉分数。结果显示 FMF 可独立预测术后 1 年全因死亡,高 FMF 组各随访节点死亡率均更高,提示其可作为衰弱相关风险分层指标。
要点
- 术前增强 CT 动脉期 L3 层面即可测量 FMF,无需额外检查
- FMF 高三分位患者术后 30 天和 1 年死亡率明显升高,阅片时应关注肌肉脂肪浸润程度
- FMF 与年龄、性别共同构成 1 年死亡独立预测因素
核心结论
- CT 衍生的脂肪肌肉分数作为一种潜在新型衰弱标志物,与 M-TEER 术后全因死亡独立相关,可用于风险分层
研究设计与样本
- 单中心回顾性研究,纳入 2010 至 2022 年 Heart Center Bonn 接受 M-TEER 且有术前增强 CT 的 197 例患者,中位年龄 79.3 岁,男性 54.3%
- 在动脉期图像上利用深度学习分割算法评估 L3 椎体层面骨骼肌数量和脂肪肌肉分数,随访术后 30 天、1 年、2 年、3 年
诊断标准与关键数值
- 1 年存活者 FMF 中位数为 49.0%(IQR 39.0–58.7),低于非存活者的 57.6%(IQR 49.6–69.2),P<0.001
- 按 FMF 三分位分组:低(<44.42%)、中(44.42–56.69%)、高(>56.69%)
- 高 FMF 组 30 天、1 年、2 年、3 年全因死亡率分别为 16.7%、30.3%、36.4%、37.9%;低 FMF 组分别为 1.5%、7.7%、12.3%、13.8%
- 多变量 Cox 回归显示 FMF 每升高 1%,1 年死亡 HR 为 1.05(95% CI 1.02–1.08,P<0.001)
临床应用与阅片要点
- 可在术前增强 CT 动脉期 L3 层面用深度学习工具自动分割并量化 FMF,辅助 M-TEER 术前衰弱评估
- 报告时可关注肌肉密度降低、脂肪浸润等表现,提示临床存在较高的术后死亡风险
局限性
- 单中心回顾性研究设计
英文原文(摘要)· 点击展开
Circulation: Cardiovascular Imaging, Volume 19, Issue 10, Page e018763, October 1, 2026. BACKGROUND:Frailty is a risk factor for adverse outcomes in patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER) and is interrelated with sarcopenia. This study aimed to investigate the prognostic value of fatty muscle fraction (FMF), measured from routine preinterventional computed tomography, as an imaging biomarker for frailty in patients undergoing M-TEER.METHODS:In patients undergoing M-TEER between 2010 and 2022 at the Heart Center Bonn who received preprocedural contrast-enhanced computed tomography, skeletal muscle quantity and quality at the L3 vertebral level were assessed on arterial-phase images using a deep learning-based segmentation algorithm. Fatty muscle fraction (FMF) was quantified and correlated with anthropometric, clinical, echocardiographic, and laboratory parameters. The primary end point was all-cause mortality at 1 year following the procedure, with additional follow-up at 30 days, 2 years, and 3 years.RESULTS:A total of 197 patients (median age, 79.3 years [interquartile range, 75.0–84.0]; 54.3% men; median European System for Cardiac Operative Risk Evaluation II, 4.1 [2.6–5.8]) were investigated. One-year survivors had significantly lower FMF values than nonsurvivors (49.0% [39.0–58.7] versus 57.6% [49.6–69.2];P<0.001). Patients were divided into tertiles according to the extent of FMF: low FMF (<44.42%), medium FMF (44.42–56.69%), and high FMF (>56.69%). Following M-TEER, high FMF was associated with a higher all-cause mortality at 30 days (16.7% versus 6.1% versus 1.5%;P=0.005), 1 year (30.3% versus 19.7% versus 7.7%;P=0.004), 2 years (36.4% versus 22.7% versus 12.3%;P=0.005) and 3 years (37.9% versus 22.7% versus 13.8%;P=0.005) follow-up. Multivariable Cox regression analysis for 1-year mortality revealed age (hazard ratio, 0.96 [95% CI, 0.93–1.00];P=0.023), male sex (hazard ratio, 3.65 [95% CI, 1.67–7.975];P<0.001), and FMF (hazard ratio, 1.05 [95% CI, 1.02–1.08];P<0.001) as independent predictors of 1-year all-cause mortality.CONCLUSIONS:Computed tomography-derived FMF, as a potentially new frailty marker, is independently associated with all-cause mortality in patients undergoing M-TEER and may serve as a promising parameter for risk stratification.
引用
- Circulation: Cardiovascular Imaging:Opportunistic CT Fatty Muscle Fraction for Outcome Prediction in Patients Undergoing Transcatheter Mitral Valve Edge-to-Edge Repair
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。